Evaluating Non-Invasive Haptics During Extreme Exercise

N/AEnrolling By InvitationNCT07285252

SuperPatch Limited LLC75 enrolled

Overview

This study aims to compare determinants of endurance performance between participants wearing an active patch with haptic vibrotactile trigger technology (VTT) versus a placebo patch without VTT among recreational to competitive runners over a 4-week training period.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

BASIC_SCIENCE

Masking

DOUBLE

Enrollment

Conditions

VO2max Lactate Threshold Lactate

Interventions

Victory Patch with Haptic Vibrotactile Trigger TechnologyDEVICE

Active Patch with Haptic Vibrotactile Trigger Technology

Sham patchDEVICE

Sham/Placebo Patch without Haptic Vibrotactile Trigger Technology

Eligibility

Sex: ALLMin age: 18 YearsMax age: 85 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adults aged 18 years and over, that participate in recreational to competitive distance running (\>2 structured runs per week), that were able to complete maximal treadmill exercise safely and were able to attend three laboratory visits were invited to participate. Exclusion Criteria: * Adults with a contraindications to high-intensity treadmill exercise, cardiovascular, metabolic, or musculoskeletal conditions limiting participation, reported use of performance-enhancing drugs, pregnancy, known allergy to adhesives, or current use of neuromodulatory or haptic devices

Locations (1)

The Altitude Centre

London, UK, United Kingdom

Outcomes

Primary Outcomes

Change in VO2 Max

Change in VO₂max (mL/kg-¹/min-¹, calculated as a 30-second rolling average)

Time frame: 2-weeks and 4-weeks after baseline assessment

Secondary Outcomes

Change in Lactate-threshold running speed

Measurement of Lactate-threshold running speed using capillary sampling (LT, km/h-¹), determined using a DmodMax algorithm on lactate-speed curves \[15\], (2) serum lactate level at threshold (mmol·L-¹).

Time frame: 2-weeks and 4-weeks after baseline assessment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.